Reuters logo
BRIEF-AstraZeneca and Merck submit application for breast cancer drug in Japan
2017年10月23日 / 早上6点33分 / 1 个月前

BRIEF-AstraZeneca and Merck submit application for breast cancer drug in Japan

Oct 23 (Reuters) - Astrazeneca Plc

* ‍ASTRAZENECA AND MSD RAPIDLY ADVANCE LYNPARZA IN JAPAN WITH A SECOND REGULATORY SUBMISSION​

* ‍JAPAN NDA IS BASED ON POSITIVE RESULTS FROM PHASE III OLYMPIAD TRIAL PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below